Larry Robbins portfolio
Glenview Capital Management
Glenview Capital Management's 13F filing for Q2 2026, filed with the SEC on August 14, 2026, reports $5B across 42 US-listed positions. The largest holding is GPN at 12.9% of the portfolio; the ten largest make up 64%. The largest buy last quarter was A, a new position ($261.6M).
Key facts
- 13F portfolio value
- $5BQ2 2026
- Positions
- 42
- Largest holding
- GPN 12.9%
- Top 10 share
- 64%
- New positions
- 12since Q1 2026
- Sold out
- 11
- Filed
- Aug 14, 2026
- Next 13F due
- Nov 16, 2026Q3 2026
Holdings as of (Q2 2026), filed with the SEC on . Changes are measured against the filing for Mar 31, 2026. Source: SEC EDGAR, Form 13F-HR of Glenview Capital Management (CIK 1138995).
Prices as of .
Compared with Q1 2026, Larry Robbins opened 12 new positions (A, LLY, MKSI…), added to 14, trimmed 15, sold out of 11 (DXC, GTM, USFD…).
By sector, Health Care is the largest at 52% of the reported portfolio, followed by Financials at 13%; 6% is in securities with no sector on file.
10 of the 42 positions listed have been in every one of the last 9 quarterly filings.
Larry Robbins top holdings: stocks in the Q2 2026 13F
| # | Stock | Sector | Share of portfolio | Value | Shares | Reported price | Price now | Since period end | Held | Last quarter |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Global PMTS IncGPN | Financials | 12.9% | $646.3M | 8.91M | $72.56 | $88.31 | 21.7% up | 9+ qtrs | ▲ Added 40% |
| 2 | CVS Health CorpCVS | Health Care | 9.97% | $499.1M | 4.82M | $103.45 | $86.77 | 16.1% down | 9+ qtrs | ▼ Reduced 41% |
| 3 | Tenet Healthcare CorpTHC | Health Care | 8.36% | $418.2M | 2.24M | $187.08 | $285.09 | 52.4% up | 9+ qtrs | ▲ Added 47% |
| 4 | Thermo Fisher Scientific IncTMO | Health Care | 6.28% | $314.5M | 627.24K | $501.36 | $691.40 | 37.9% up | 5 qtrs | ▲ Added 150% |
| 5 | Amazon.com IncAMZN | Consumer Discretionary | 6.05% | $303.1M | 1.27M | $238.34 | $256.22 | 7.5% up | 9+ qtrs | ▲ Added 20% |
| 6 | Agilent Technologies IncA | Health Care | 5.23% | $261.6M | 1.97M | $132.83 | $172.97 | 30.2% up | 1 qtr | New |
| 7 | Danaher CorpDHR | Health Care | 4.36% | $218.3M | 1.15M | $190.48 | $226.71 | 19.0% up | 5 qtrs | ▲ Added 633% |
| 8 | Meta Platforms IncMETA · CL A | Communication | 4.02% | $201M | 356.84K | $563.29 | $619.72 | 10.0% up | 6 qtrs | ▲ Added 191% |
| 9 | Advanced Micro Devices IncAMD | Technology | 3.46% | $173.3M | 298.41K | $580.91 | $493.46 | 15.1% down | 3 qtrs | ▼ Reduced 54% |
| 10 | Teva Pharmaceutical IndustriesTEVA · SPONSORED ADS | Health Care | 3.44% | $172.1M | 5.08M | $33.88 | $42.18 | 24.5% up | 9+ qtrs | ▼ Reduced 24% |
| 11 | Viatris IncVTRS | Health Care | 3.13% | $156.9M | 9.88M | $15.88 | $20.64 | 29.9% up | 9+ qtrs | ▲ Added 8.7% |
| 12 | Uber Technologies IncUBER | Industrials | 2.59% | $129.4M | 1.79M | $72.16 | $68.41 | 5.2% down | 9+ qtrs | ▲ Added 23% |
| 13 | Centene CorpCNC | Health Care | 2.42% | $121.1M | 1.89M | $64.19 | $73.63 | 14.7% up | 4 qtrs | ▼ Reduced 41% |
| 14 | Butterfly Network IncBFLY | — | 2.41% | $120.7M | 14.34M | $8.42 | $5.82 | 30.9% down | 9+ qtrs | No change |
| 15 | The Cigna GroupCI | Health Care | 2.27% | $113.6M | 412.22K | $275.68 | $297.67 | 8.0% up | 9+ qtrs | ▼ Reduced 17% |
| 16 | Humana IncHUM | Health Care | 2.02% | $101M | 254.22K | $397.22 | $444.42 | 11.9% up | 2 qtrs | ▼ Reduced 24% |
| 17 | Block IncXYZ · CL A | Technology | 1.82% | $91M | 1.2M | $76.00 | $80.17 | 5.5% up | 4 qtrs | ▼ Reduced 12% |
| 18 | Dicks Sporting Goods IncDKS | Consumer Discretionary | 1.82% | $91M | 401.07K | $226.81 | $143.78 | 36.6% down | 5 qtrs | ▲ Added 34% |
| 19 | Genius Sports LtdGENI · SHARES CL A | — | 1.63% | $81.8M | 13.5M | $6.06 | $6.01 | 0.8% down | 3 qtrs | ▲ Added 58% |
| 20 | Onto Innovation IncONTO | Technology | 1.56% | $77.9M | 205.79K | $378.45 | $199.57 | 47.3% down | 4 qtrs | ▼ Reduced 31% |
| 21 | Eli Lilly & CoLLY | Health Care | 1.38% | $69.3M | 57.77K | $1,199.43 | $1,417.79 | 18.2% up | 1 qtr | New |
| 22 | United Airls Hldgs IncUAL | Industrials | 1.34% | $67.3M | 494.74K | $135.99 | $107.94 | 20.6% down | 6 qtrs | ▼ Reduced 0.4% |
| 23 | National Vision Holdings IncEYE | — | 1.18% | $59M | 3.1M | $19.01 | $18.10 | 4.8% down | 5 qtrs | ▲ Added 98% |
| 24 | Cisco Systems IncCSCO | Technology | 0.97% | $48.5M | 413.33K | $117.46 | $94.70 | 19.4% down | 2 qtrs | ▲ Added 22% |
| 25 | Element Solutions IncESI | Materials | 0.95% | $47.5M | 994.58K | $47.75 | $31.74 | 33.5% down | 9+ qtrs | ▼ Reduced 39% |
| 26 | Applied Materials IncAMAT | Technology | 0.94% | $47.1M | 65.2K | $723.00 | $347.56 | 51.9% down | 3 qtrs | ▼ Reduced 67% |
| 27 | MKS IncMKSI | Industrials | 0.88% | $43.8M | 98.53K | $444.80 | $203.96 | 54.1% down | 1 qtr | New |
| 28 | Six Flags Entertainment CorpFUN | — | 0.86% | $43M | 2.02M | $21.30 | $11.02 | 48.3% down | 3 qtrs | ▼ Reduced 9.2% |
| 29 | Stmicroelectronics N VSTM · NY REGISTRY | Technology | 0.84% | $41.9M | 560.06K | $74.89 | $44.19 | 41.0% down | 1 qtr | New |
| 30 | AbbVie IncABBV | Health Care | 0.75% | $37.5M | 148.91K | $251.64 | $293.39 | 16.6% up | 1 qtr | New |
| 31 | AstraZeneca PLCAZN · ORD | Health Care | 0.70% | $34.9M | 184.28K | $189.62 | $183.45 | 3.3% down | 1 qtr | New |
| 32 | Bausch Plus Lomb CorpBLCO | Health Care | 0.64% | $31.8M | 1.92M | $16.56 | $20.98 | 26.7% up | 6 qtrs | ▲ Added 0.4% |
| 33 | Baker Hughes CoBKR · CL A | Energy | 0.55% | $27.4M | 493.52K | $55.50 | $48.01 | 13.5% down | 2 qtrs | ▲ Added 63% |
| 34 | Elevance HealthELV | Health Care | 0.51% | $25.8M | 66.6K | $386.73 | $438.25 | 13.3% up | 1 qtr | New |
| 35 | Microchip Technology IncMCHP | Technology | 0.48% | $24.2M | 265.58K | $91.20 | $59.92 | 34.3% down | 1 qtr | New |
| 36 | Bruker CorpBRKR | Health Care | 0.30% | $15.2M | 252.17K | $60.18 | $61.53 | 2.2% up | 1 qtr | New |
| 37 | Novartis AGNVS · SPONSORED ADR | Health Care | 0.27% | $13.6M | 86.91K | $156.72 | $159.90 | 2.0% up | 1 qtr | New |
| 38 | Digitalocean Holdings IncDOCN | Technology | 0.27% | $13.3M | 84.81K | $157.03 | $78.27 | 50.2% down | 3 qtrs | ▼ Reduced 66% |
| 39 | Primo Brands CorporationPRMB · CLASS A COM SHS | Consumer Staples | 0.20% | $9.9M | 404.97K | $24.44 | $24.34 | 0.4% down | 2 qtrs | ▼ Reduced 24% |
| 40 | Boston Scientific CorpBSX | Health Care | 0.10% | $4.8M | 113.1K | $42.68 | $43.21 | 1.2% up | 1 qtr | New |
| 41 | Cardinal Health IncCAH | Health Care | 0.09% | $4.3M | 18.02K | $237.56 | $282.87 | 19.1% up | 1 qtr | New |
| 42 | Bio-Techne CorpTECH | Health Care | 0.08% | $4.1M | 58.32K | $70.65 | $72.79 | 3.0% up | 4 qtrs | ▼ Reduced 69% |
Larry Robbins latest buys (Q2 2026)
Larry Robbins latest sells (Q2 2026)
Every buy and sell in Larry Robbins' Q2 2026 13F →
By sector
| Sector | Share of portfolio | Value | Positions |
|---|---|---|---|
| Health Care | 52.3% | $2.6B | 20 |
| Financials | 12.9% | $646.3M | 1 |
| Technology | 10.3% | $517.4M | 8 |
| Consumer Discretionary | 7.87% | $394.1M | 2 |
| Industrials | 4.80% | $240.5M | 3 |
| Communication | 4.02% | $201M | 1 |
| Materials | 0.95% | $47.5M | 1 |
| Energy | 0.55% | $27.4M | 1 |
| Consumer Staples | 0.20% | $9.9M | 1 |
| No sector on file | 6.08% | $304.4M | 4 |
8 quarterly filings on file for Glenview Capital Management, back to Q3 2024: reported value, position counts, and every buy and sell quarter by quarter.
Filing history →All Q2 2026 13F filings →Questions about Larry Robbins' portfolio
What stocks does Larry Robbins own?
According to Glenview Capital Management's 13F filing for Q2 2026, the largest of its 42 US-listed positions are GPN (12.9%), CVS (10.0%), THC (8.4%), TMO (6.3%) and AMZN (6.1%). A 13F shows long positions only, as of the quarter's end.
What is Larry Robbins' largest holding?
GPN (Global PMTS Inc), worth $646.3M at the end of Q2 2026, or 12.9% of the $5B Glenview Capital Management reported.
What did Larry Robbins buy last quarter?
In Q2 2026, compared with the filing for Q1 2026, the largest purchases were A (new position, $261.6M), TMO (added, $188.9M), DHR (added, $188.5M), GPN (added, $184.7M) and THC (added, $133M).
What did Larry Robbins sell last quarter?
In Q2 2026 the largest sales were CVS (reduced, $348.9M), AMD (reduced, $204.7M), DXC (sold out, $111.8M), AMAT (reduced, $95.4M) and GTM (sold out, $95.1M), against the filing for Q1 2026.
How much is Larry Robbins' portfolio worth?
Glenview Capital Management reported $5B in 42 US-listed positions for Q2 2026, valued at the quarter's end and filed on August 14, 2026. That is the 13F portfolio only: no cash, short positions or most shares listed outside the US.
When does Larry Robbins file the next 13F?
The 13F for Q3 2026, the quarter ending September 30, 2026, was due by November 16, 2026: 45 days after the quarter ends, or the next business day. The latest filing on file here is for Q2 2026, filed on August 14, 2026.
Which sectors does Larry Robbins own?
Health Care 52.3%, Financials 12.9%, Technology 10.3%, Consumer Discretionary 7.9%, Industrials 4.8% of the reported portfolio, with 6.1% in securities that have no sector on file here (funds, smaller companies, positions without a ticker).
How long has Larry Robbins held these stocks?
Counting consecutive quarterly filings up to Q2 2026: GPN 9+, CVS 9+, THC 9+, TMO 5, AMZN 9+, A 1. “9+” means the position is in every filing looked at, so it may go back further.
Learn
Cite this page
Funkfolio, “Larry Robbins portfolio: Glenview Capital Management 13F holdings (Q2 2026)”, data as of 14 August 2026. https://funkfolio.com/gurus/larry-robbins
Underlying data: SEC EDGAR, Form 13F-HR of Glenview Capital Management (CIK 1138995) for the period ending June 30, 2026.
Source: SEC EDGAR, Form 13F-HR for Glenview Capital Management (CIK 1138995), period ending Jun 30, 2026, filed Aug 14, 2026. “Last quarter” compares share counts with the filing for Mar 31, 2026. 3 option positions in the filing are not shown. “Reported price” is the position's reported value divided by its shares — the price the filing implies for the period end. “Price now” is from Yahoo Finance and can be delayed 15 minutes or more; “since period end” sets the two side by side and is left blank where the reported price falls outside the stock's 52-week range, which points to a share split since. A split small enough to stay inside that range is not caught, and dividends are not counted. Sectors are those of the ranked companies on this site; funds, smaller companies and positions without a ticker have none. “Held” counts consecutive quarterly filings the position appears in, out of the 9 looked at. A buy or sell is sized as the shares moved at the price the filing implies; a position sold out at its value in the previous filing. Filings can be 45 days old when published; this is not a live portfolio and not advice.